Sunday, July 22, 2018

HotSpot Therapeutics debuts with $45 million to pursue allosteric inhibitors

The company claims its technology will allow it to access previously undruggable targets

via Chemical & Engineering News: Biological SCENE https://ift.tt/2NCh0JX
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)